Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 1,326 | 640 | 0 | 0 | 0 |
| Cost of Goods | 214 | 110 | N/A | N/A | N/A |
| Gross Profit | 1,112 | 530 | N/A | N/A | N/A |
| Operating Expenses | 17,189 | 14,195 | 11,590 | 10,248 | 9,962 |
| Operating Income | -15,863 | -13,555 | -11,590 | -10,248 | -9,962 |
| Other Income | 422 | 518 | 349 | 277 | 232 |
| Pre-tax Income | -15,441 | -13,037 | -11,241 | -9,971 | -9,730 |
| Net Income Continuous | -15,441 | -13,037 | -11,241 | -9,971 | -9,730 |
| Net Income | $-15,441 | $-13,037 | $-11,241 | $-9,971 | $-9,730 |
| EPS Basic Total Ops | -0.46 | -0.39 | -0.39 | -0.36 | -0.35 |
| EPS Basic Continuous Ops | -0.47 | -0.39 | -0.39 | -0.36 | -0.35 |
| EPS Diluted Total Ops | -0.46 | -0.39 | -0.39 | -0.36 | -0.35 |
| EPS Diluted Continuous Ops | -0.47 | -0.39 | -0.39 | -0.36 | -0.35 |
| EBITDA(a) | $-15,624 | $-13,417 | $-11,456 | $-10,133 | $-9,794 |